Cerus Corp (CERS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cerus Corp (CERS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7147
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide range of pathogens including viruses, bacteria and parasites present in donated blood. The product is for use with three blood components, platelets, plasma and red blood cells. Cerus is marketed and sold in several countries worldwide including the US, Belgium, Kuwait, France, Spain, Portugal, Switzerland, CIS countries and other countries. Cerus is headquartered in Concord, California, the US.

Cerus Corp (CERS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cerus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cerus Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cerus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cerus Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cerus Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cerus Corp, Medical Equipment, Deal Details 10
Partnerships 10
Cerus Enters into Agreement with Kedrion Biopharma 10
Cerus Enters into Agreement with Haemonetics 11
Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 12
Cerus Enters into Co-Marketing Agreement with Biomedica Foscama 13
Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 14
Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 15
Equity Offering 16
Cerus Raises USD57.5 Million in Public Offering of Shares 16
Cerus Plans to Raise USD70 Million in Public Offering of Shares 17
Cerus Prices Public Offering of Shares for USD70 Million 18
Cerus Completes Public Offering Of Shares For US$40.3 Million 19
Cerus Corp – Key Competitors 21
Cerus Corp – Key Employees 22
Cerus Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 02, 2018: Cerus announces second quarter 2018 financial results 24
May 08, 2018: Cerus Reports First Quarter 2018 Results 26
Mar 08, 2018: Cerus Reports Fourth Quarter And Year End 2017 Financial Results 28
Jan 08, 2018: Cerus Announces Preliminary Product Revenue Results for Fourth Quarter and Full Year 2017 30
Nov 02, 2017: Cerus Corporation Reports Third Quarter 2017 Results 31
Aug 03, 2017: Cerus Reports Second Quarter 2017 Results 33
May 03, 2017: Cerus Reports First Quarter 2017 Results 35
Mar 07, 2017: Cerus Reports Fourth Quarter and Year End 2016 Results 36
Corporate Communications 38
Oct 09, 2018: Cerus appoints Eric Bjerkholt to board of directors 38
Other Significant Developments 39
Oct 31, 2017: Cerus and Kedrion Biopharma Enter Distribution Agreement for the Full INTERCEPT Blood System Portfolio in Italy 39
Jun 07, 2017: Cerus Provides Update on U.S. Platelet Additive Solution Supply 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Cerus Corp, Medical Equipment, Key Facts, 2017 2
Cerus Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cerus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cerus Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cerus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cerus Corp, Deals By Market, 2012 to YTD 2018 8
Cerus Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cerus Enters into Agreement with Kedrion Biopharma 10
Cerus Enters into Agreement with Haemonetics 11
Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 12
Cerus Enters into Co-Marketing Agreement with Biomedica Foscama 13
Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 14
Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 15
Cerus Raises USD57.5 Million in Public Offering of Shares 16
Cerus Plans to Raise USD70 Million in Public Offering of Shares 17
Cerus Prices Public Offering of Shares for USD70 Million 18
Cerus Completes Public Offering Of Shares For US$40.3 Million 19
Cerus Corp, Key Competitors 21
Cerus Corp, Key Employees 22
Cerus Corp, Subsidiaries 23

List of Figures
Cerus Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cerus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cerus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cerus Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cerus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cerus Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cerus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cerus Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cerus Corp (CERS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • C.A. Curtze Co. Inc.:企業の戦略・SWOT・財務分析
    C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • NextEra Energy Inc (NEE):企業の財務・戦略的SWOT分析
    NextEra Energy Inc (NEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mach7 Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mach7 Technologies Inc (Mach7) is a healthcare technology company that offers enterprise image management solutions. The company offers solutions such as archive and communication, access and share, manage data and services. Its products include communication workflow engine, vendor neutral …
  • Samsung Securities Co Ltd (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co Ltd (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • PTC Inc (PTC):企業の財務・戦略的SWOT分析
    PTC Inc (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • GenMark Diagnostics Inc (GNMK):企業の財務・戦略的SWOT分析
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test …
  • Alberta Treasury Branches:企業の戦略的SWOT分析
    Alberta Treasury Branches - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • AT&T Inc:戦略・SWOT・企業財務分析
    AT&T Inc - Strategy, SWOT and Corporate Finance Report Summary AT&T Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Lohmann & Rauscher GmbH & Co. KG:企業の戦略的SWOT分析
    Lohmann & Rauscher GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Northrop Grumman Technical Services Inc.:企業の戦略・SWOT・財務分析
    Northrop Grumman Technical Services Inc. - Strategy, SWOT and Corporate Finance Report Summary Northrop Grumman Technical Services Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Spectrum Pharmaceuticals Inc (SPPI):企業の財務・戦略的SWOT分析
    Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Scoular Company:戦略・SWOT・企業財務分析
    The Scoular Company - Strategy, SWOT and Corporate Finance Report Summary The Scoular Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Tetherex Pharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Tetherex Pharmaceuticals Corp (Tetherex Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops novel medicines for the treatment of inflammation, thrombosis and tumor metastasis. Its lead pipeline product candidate SelK2, a humanized monoclonal antibody targets a cell …
  • Mobile Telesystems
    Mobile Telesystems - Strategy, SWOT and Corporate Finance Report Summary Mobile Telesystems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Verde Science Inc-石油・ガス分野:企業M&A・提携分析
    Summary Verde Science Inc (Verde Science), formerly Rango Energy Inc is a medical technology company that offers bioprocess solutions. The company offers research and development services with expertise in bioprocess technology, molecular virology and immunology, nanotechnology, pharmacology and med …
  • Transgene Biotek Ltd (526139):企業の財務・戦略的SWOT分析
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes bio-generic drugs and vaccines to treat autoimmune diseases and cancer. The company’s product portfolio includes TrabiDHA, a vegetarian source of DHA (Docosahexaenoic acid), used to manufacture healt …
  • Qatar National Bank (QNBK):企業の財務・戦略的SWOT分析
    Qatar National Bank (QNBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Chronos Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Chronos Therapeutics Ltd (Chronos) is a developer of medications for degenerative and behavioural diseases of the brain and nervous system. The company offers research and development, screening, discovery, repositioning and acquisition programs. Its pipeline products comprise RDC5 neurodege …
  • Emisphere Technologies Inc (EMIS)-製薬・医療分野:企業M&A・提携分析
    Summary Emisphere Technologies Inc (Emisphere) is a specialty pharmaceutical and drug delivery company. The company in partnership with global pharmaceutical companies develops novel oral formulations of existing injectable bio-pharmaceutical products, besides new chemical entities, using its Eligen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆